Raymond W. Urbanski - 13 Aug 2024 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
CHIEF DEVELOPMENT OFFICER
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Issuer symbol
SLNO
Transactions as of
13 Aug 2024
Net transactions value
$0
Form type
4
Filing time
23 Aug 2024, 19:16:04 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLNO Stock option (right to buy) Award $0 +145,000 $0.000000 145,000 13 Aug 2024 Common Stock 145,000 $49.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares subject to the Option shall vest on August 12, 2025 and one forty-eighth of the shares subject to the Option shall vest each month thereafter on the same day of the month, subject to the Reporting Person continuing to be a Service Provider through each such date..